To access this element change to forms mode OFF
Grant Award View - GA163521
Immunoglobulin Seed Grant: A new blood test to guide immunoglobulin...
GA ID:
GA163521
Agency:
National Blood Authority
Approval Date:
10-Feb-2021
Publish Date:
6-May-2021
Category:
Medical Research
Grant Term:
16-Apr-2021 to 31-Jul-2023
Original: 16-Apr-2021 to 31-Mar-2022
Value (AUD):
$55,000.00
(GST inclusive where applicable)
Variations:
- GA163521-V1 - Delays due to COVID-19 (26-Apr-2023 )
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NBA 20/21 NBA Program 1.1 National Blood Agreement Management
Grant Program:
National Blood Sector Research and Development Program
Grant Activity:
Immunoglobulin Seed Grant: A new blood test to guide immunoglobulin replacement therapy in patients with immunodeficiency diseases
Purpose:
This study aims to:
a)develop and evaluate the performance of a novel transcriptomic assay assessing expression of the immunoglobulin heavy chain genes;
b)assess its utility as a biomarker of endogenous immunoglobulin production in patients with primary and secondary immunodeficiencies; and
c)assist in clinical decision-making regarding immunoglobulin replacement therapy (IRT) prescription.
GO ID:
GO Title:
National Blood Sector Research and Development Program – Round 5
Internal Reference ID:
ID526
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
The University of Adelaide
Recipient ABN:
61 249 878 937
Grant Recipient Location
Suburb:
North Terrace
Town/City:
Adelaide
Postcode:
5005
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
SA
Postcode:
5005
Country:
AUSTRALIA